Skip to main content

Table 1 Effects of different brimonidine eye drops formulations on neutrophil migration

From: The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations

Drugs (1:100 dilution)Migration distance ± SD (μm)
BT 0.2% with BAK (Alcon Inc)a62.14 ± 3.71
BT 0.2% with BAK (Allergan Inc)a63.61 ± 3.81
BT 0.15% without BAK (Allergan Inc)b40.36 ± 3.17
BAK-Sb41.02 ± 2.17
PBSc37.57 ± 2.14
ZASd77.21 ± 3.95
fMLPd100.71 ± 3.94
  1. (Mean migration ± standard deviation in μm)
  2. aDrugs inducing significant chemotaxis (p < 0.01 versus PBS controls)
  3. bDrugs inducing no significant chemotactic effect (p > 0.05 versus PBS controls)
  4. cNegative control
  5. dPositive controls